MRI-guided fluorescence tomography of PPIX in the breast: A case study

Progress in Biomedical Optics and Imaging - Proceedings of SPIE

Volumn 7892, Issue , 2011, Pages

  Davis, Scott C ^a   Mastanduno, Michael A ^a   Pogue, Brian W ^a   Paulsen, Keith D ^a  

^a DARTMOUTH COLLEGE   (United States)

Author keywords

breast imaging; Fluorescence tomography; MRI; multi modal imaging; protoporphyrin IX; spectroscopy

Indexed keywords

BREAST IMAGING; FLUORESCENCE TOMOGRAPHY; MRI; MULTI-MODAL IMAGING; PROTOPORPHYRIN IX;

CHEMOTHERAPY; DISEASES; FLUORESCENCE; MEDICAL IMAGING; SPECTROMETERS; TISSUE; TOMOGRAPHY;

MAGNETIC RESONANCE IMAGING;

EID: 79955415761     PISSN: 16057422     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1117/12.875775     Document Type: Conference Paper

References (22)

1. K. A. Frei, H. M. Bonel, H. Frick et al., "Photodynamic detection of diseased axillary sentinel lymph node after oral application of aminolevulinic acid in patients with breast cancer," Br J Cancer, 90(4), 805-809 (2004).
2. M. K. Akens, A. J. M. Yee, B. C. Wilson et al., "Photodynamic Therapy of Vertebral Metastases: Evaluating Tumor-to- Neural Tissue Uptake of BPD-MA and ALA-PpIX in a Murine Model of Metastatic Human Breast Carcinoma†," Photochemistry and Photobiology, 83(5), 1034-1039 (2007).
3. S. R. Millon, J. H. Ostrander, S. Yazdanfar et al., "Preferential accumulation of 5-aminolevulinic acid-induced protoporphyrin IX in breast cancer: a comprehensive study on six breast cell lines with varying phenotypes," Journal of Biomedical Optics, 15(1), 018002-8 (2010).
4. D. Ladner, R. Steiner, J. Allemann et al., "Photodynamic diagnosis of breast tumours after oral application of aminolevulinic acid," Br J Cancer., 84(1), 33-7 (2001).
5. W. Stummer, C. Goetz, H. Stepp et al., "Intraoperative detection of malignant glioma by 5-ALA induced protoporphyrin IX fluorescence," Clinical Neurology and Neurosurgery, 99(Supplement 1), S93-S93 (1997).
6. A. Godavarty, M. J. Eppstein, C. Zhang et al., "Detection of single and multiple targets in tissue phantoms with fluorescence-enhanced optical imaging: feasibility study," Radiol., 235(1), 148-54 (2005).
7. A. Godavarty, A. B. Thompson, R. Roy et al., "Diagnostic imaging of breast cancer using fluorescence-enhanced optical tomography: phantom studies," J. Biomed. Opt., 9(3), 488-96 (2004).
8. A. Godavarty, C. Zhang, M. J. Eppstein et al., "Fluorescence- enhanced optical imaging of large phantoms using single and simultaneous dual point illumination geometries," Med. Phys., 31(2), 183-90 (2004).
9. R. Weissleder, C.-H. Tung, U. Mahmood et al., "In vivo imaging of tumors with protease-activated near-infrared fluorescent probes," Nature Biotechnology, 17, 375-378 (1999).
10. V. Ntziachristos, C. H. Tung, C. Bremer et al., "Fluorescence molecular tomography resolves protease activity in vivo," Nature Medicine, 8(7), 757-60 (2002).
11. C. M. McCann, P. Waterman, J.-L. Figueiredo et al., "Combined magnetic resonance and fluorescence imaging of the living mouse brain reveals glioma response to chemotherapy," Neuroimage, 45, 360-369 (2009).
12. A. Corlu, R. Choe, T. Durduran et al., "Three-dimensional in vivo fluorescence diffuse optical tomography of breast cancer in humans," Optics Express, 15(11), 6696-6716 (2007).
13. C. Li, G. S. Mitchell, J. Dutta et al., "A three-dimensional multispectral fluorescence optical tomography imaging system for small animals based on a conical mirror design," Opt Express, 17(9), 7571-85 (2009).
14. V. Ntziachristos, E. A. Schellenberger, J. Ripoll et al., "Visualization of antitumor treatment by means of fluorescence molecular tomography with an annexin V-Cy5.5 conjugate," Proceedings of the National Academy of Sciences of the United States of America, 101(33), 12294-9 (2004).
15. S. C. Davis, K. S. Samkoe, J. A. O'Hara et al., "MRI-coupled fluorescence tomography quantifies EGFR activity in brain tumors," Acad. Radiol., 17(3), 271-276 (2010).
16. S. C. Davis, B. W. Pogue, R. Springett et al., "Magnetic resonance-coupled fluorescence tomography scanner for molecular imaging of tissue," Rev. Sci. Instr., 79(6), 064302-1 to 064302-10 (2008).
17. C. M. Carpenter, B. W. Pogue, H. Jiang et al., "Image-guided optical spectroscopy provides molecular-specific information in vivo: MRI-guided spectroscopy of breast cancer hemoglobin, water, and scatterer size," Optics Letters, 32(8), 933-935 (2007).
18. B. Brooksby, H. Dehghani, B. W. Pogue et al., "Near infrared (NIR) tomography breast image reconstruction with a priori structural information from MRI: algorithm development for reconstructing heterogeneities," IEEE J. STQE, 9, 199-209 (2003).
19. B. Brooksby, S. Jiang, C. Kogel et al., "Magnetic resonance-guided near-infrared tomography of the breast," Rev. Sci. Instrum., 75(12), 5262-5270 (2004).
20. H. Dehghani, M. E. Eames, P. K. Yalavarthy et al., "Near infrared optical tomography using NIRFAST: Algorithm for numerical model and image reconstruction," Communications in Numerical Methods in Engineering, DOI: 10.1002/cnm, (accepted 25 June 2008, in press), (2008).
21. S. C. Davis, H. Dehghani, J. Wang et al., "Image-guided diffuse optical fluorescence tomography implemented with Laplacian-type regularization," Optics Express, 15(7), 4066-4082 (2007).
22. S. C. Davis, K. S. Samkoe, J. A. O'Hara et al., "Comparing implementations of magnetic-resonance-guided fluorescence molecular tomography for diagnostic classification of brain tumors," Journal of Biomedical Optics, 15(5), 051602-10 (2010).